Pharmacokinetics of flunixin across different stages of gestation: a controlled study in goats

Treating pain and inflammation is vital for the health and welfare of pregnant goats. Flunixin is a widely used anti-inflammatory drug, but it is unknown how the physiological changes during gestation alter its pharmacokinetics. This study compared the pharmacokinetic profile of flunixin in pregnant goats at different stages of pregnancy (days 45, 90, and 135). The experiment comprised twelve goats: six non-pregnant and six pregnant. Pharmacokinetic studies were performed in pregnant goats on days 45, 90, and 135 of gestation and also in non-pregnant goats during the same periods. Flunixin was administered in both pregnant and non-pregnant goats via intramuscular (IM) injection at a dose of 2.2 mg/kg. Plasma flunixin concentrations were assessed by HPLC. No local or systemic side effects were observed in pregnant or non-pregnant goats. The terminal elimination half-life, area under the concentration–time curve (AUC 0−last ), total body clearance (Cl T /F), apparent volume of distribution (V darea /F), and peak plasma concentration (C max ) after IM injection in non-pregnant goats were 3.46–3.51 h, 28.40–31.99 h*µg/mL, 0.07–0.08 L/h/kg, 0.34–0.39 L/kg, and 9.62–11.54 µg/mL, respectively. No differences were observed in pharmacokinetic parameters over time ( p > 0.05). Progress of gestation had no significant effect on the pharmacokinetic parameters. The AUC 0−last , Cl T /F, V darea /F, and C max values showed significant differences between pregnant and non-pregnant goats ( p < 0.05). Pregnant goats exhibited elevated AUC 0−last and C max and reduced Cl T /F and V darea /F for flunixin in comparison to non-pregnant goats ( p < 0.05). The pharmacokinetics of flunixin differ significantly in pregnant goats compared to non-pregnant goats, and it should be used with caution in pregnant goats due to high drug levels.

Authors

Institutions

Publication Details

Journal
BMC Veterinary Research
Published
2026-11-17
DOI
https://doi.org/10.1186/s12917-026-06114-2
Primary Topic
Veterinary Pharmacology and Anesthesia
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pharmacokinetics of flunixin across different stages of gestation: a controlled study in goats

İsmail Arı, Mustafa Hitit, Duygu Durna Çorum, Kamil Üney et al.
BMC Veterinary Research
Veterinary Pharmacology and Anesthesia
article

Pharmacokinetics of flunixin across different stages of gestation: a controlled study in goats

İsmail Arı, Mustafa Hitit, Duygu Durna Çorum, Kamil Üney, Orhan Çorum, Erdinç Türk, Devran Coşkun, Murat Yüksel
article en

Abstract

Treating pain and inflammation is vital for the health and welfare of pregnant goats. Flunixin is a widely used anti-inflammatory drug, but it is unknown how the physiological changes during gestation alter its pharmacokinetics. This study compared the pharmacokinetic profile of flunixin in pregnant goats at different stages of pregnancy (days 45, 90, and 135). The experiment comprised twelve goats: six non-pregnant and six pregnant. Pharmacokinetic studies were performed in pregnant goats on days 45, 90, and 135 of gestation and also in non-pregnant goats during the same periods. Flunixin was administered in both pregnant and non-pregnant goats via intramuscular (IM) injection at a dose of 2.2 mg/kg. Plasma flunixin concentrations were assessed by HPLC. No local or systemic side effects were observed in pregnant or non-pregnant goats. The terminal elimination half-life, area under the concentration–time curve (AUC 0−last ), total body clearance (Cl T /F), apparent volume of distribution (V darea /F), and peak plasma concentration (C max ) after IM injection in non-pregnant goats were 3.46–3.51 h, 28.40–31.99 h*µg/mL, 0.07–0.08 L/h/kg, 0.34–0.39 L/kg, and 9.62–11.54 µg/mL, respectively. No differences were observed in pharmacokinetic parameters over time ( p > 0.05). Progress of gestation had no significant effect on the pharmacokinetic parameters. The AUC 0−last , Cl T /F, V darea /F, and C max values showed significant differences between pregnant and non-pregnant goats ( p < 0.05). Pregnant goats exhibited elevated AUC 0−last and C max and reduced Cl T /F and V darea /F for flunixin in comparison to non-pregnant goats ( p < 0.05). The pharmacokinetics of flunixin differ significantly in pregnant goats compared to non-pregnant goats, and it should be used with caution in pregnant goats due to high drug levels.

BMC Veterinary Research
Selçuk University (TR), Siirt Üniversitesi (TR), Dokuz Eylül University (TR), Prairie View A&M University (US), Mustafa Kemal University (TR)
Good health and well-being, Zero hunger
Veterinary Pharmacology and Anesthesia
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon